GPC3 and hepatocellular carcinoma: The drug vehicle control mAKT/NRAS group developed HCC tumors as judged by H&E staining, histology and IHC staining with tumor markers beta-Catenin and Gpc3 (Figure 8A-B), with a mean survival time of 70 days (Figure 8C).